ValoDia® VALODIA Consortium Developing a knowledge- based economy with commercialisation of science and international investors Peter Lindholm

ValoDia® Empirical Findings  A Knowledge-based economy implies a vibrant innovation ecosystem shared by all stakeholders  Scientific goods (knowledge, products, patents, etc.) need to meet demands from companies to contribute to the economic development of the country  Facilitating the links between business and research players, overcoming any hurdle, including from the point of view of cultural differences implies hands-on support from specialists  It is essential the parties agree on win-win agreements that will lead to long-term partnerships  When possible, it is best to create joint-ventures or joint start-ups

ValoDia® Conceptual approach  Need to attract high level “brains”  Need to facilitate the commercialisation of scientific results to help absorption by local and foreign companies (existing and start- ups)  Importance of attracting inward investors with the quality of local R&D teams and develop joint projects

ValoDia® R&D expenditure % of GDP

ValoDia® High tech Exports from Kazakhstan ($)

ValoDia® The commercialisation of science paradigm shift: being “demand Driven”  N°1: Search for European companies with technological needs  N°2: Selecting only those firms that have financial capabilities to pay for a collaboration and strong willingness  N°3: Search for R&D teams that are capable, ready and willing to enter into a concrete negotiations  N°4: Helping the European and Kazakh sides becoming more and more specific  N°5: Assisting the technology due diligence, Intellectual Property Rights, cultural differences, contractual issues, business planning, marketing, etc.  N°6: Facilitating the conclusion of “Good & Fair” deals  N°7: Continuously supporting the “pairs” when created

ValoDia® Expected outputs Attraction of inward investors to the country Implementation of international good practices A concrete and measurable return-on- investment based on money, number of collaborations, joint start-ups, etc. Expected financial return, based on European and Kazakh projects ≈ 30 times the costs of commercialisation

ValoDia® 8 Activities developed in 2008/9: French-Russian G8GP Programme Within 18 months: 12 Russo-European technology pairs created and supported short term value ≈ 1,3 mln. Euro Medium term Value ≈ 35 mln. Euro

ValoDia® French-Russian G8GP Programme EXAMPLE 1: ARENZO MOLECULAR DIAGNOSTICS Kit and System:  A French medium sized biotechnology firm  A biological Institute that develops an innovative bio-chip  An international market for diagnosis in HCV Subtyping RUO, HCV Subtyping CE, Oncogenic viruses, etc. Creation of a Joint Venture to:  Market joint products throughout the world  Adapt the Russian chip to international standards and increase its possibilities  Expected results: a turn-over of ≈ € Per Annum after the development phase (2 years +)

ValoDia® French-Russian G8GP Programme EXAMPLE 2: HEF/HCEI Filtered arc technology for deposition of coatings on metal surfaces:  A French company - European leader in the field of surface engineering  A research institute in Tomsk that develops the filtered arc technology Creation of a Joint Venture to:  Produce technological blocks in Tomsk to integrate in HEF equipment  Build surface treatment machines in Tomsk  Create a sales network in Russia  Expected results: a turn-over ≈ € Per Annum after the development phase and establishment of the JV (3 years +)

ValoDia® Thank you for attention! For any questions feel free to contact Peter Lindholm at